Zoledronic Acid-Induced Insulitis in Rats

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 73

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TIPS-9-2_007

تاریخ نمایه سازی: 10 مرداد 1402

چکیده مقاله:

Insulitis is the inflammation of beta cells of the Langerhans islets. It is well-known that insulitis is a prevalent complication of diabetes. A series of xenobiotics, including drugs, could also induce insulitis. The current study evaluated the effect of zoledronic acid (ZLD) on the pancreas in an animal model. Actually, in an attempt to evaluate the adverse effects of ZLD on the kidney, we noticed severe morphological alterations in the pancreas. Therefore, the effects of ZLD on the pancreas tissue were further investigated. Rats received ZLD (۱۰ and ۱۵ mg/kg, single dose, i.p) and pancreas weight index, serum biomarkers of pancreas injury, the level of pro-inflammatory cytokines (TNF-α, IL-۶, and IL-۱β), oxidative stress biomarkers in this organ, and pancreas histopathological alterations were assessed. A significant increase in pancreas weight index was detected in ZLD-treated animals. ZLD also significantly increased serum amylase and lipase levels. No significant changes in serum glucose were detected in this study. A significant increase in reactive oxygen species, lipid peroxidation, decreased glutathione levels, and antioxidant capacity was also evident in the pancreas of ZLD-treated rats. Histopathological findings indicate the insulitis lesions of the islets of Langerhans at both doses of ۱۰ and ۱۵ mg/kg of ZLD. The data obtained from this study revealed insulitis as a serious adverse effect associated with high doses of ZLD. Clearly, further studies are warranted to evaluate the effects of other doses and/or patterns of administration of ZLD on pancreas tissue and, finally, the clinical significance of these data.

نویسندگان

Heresh Rezaei

Pharmaceutical Sciences Research Center, Shiraz University Of Medical Sciences, Shiraz, Iran

Akram Jamshidzadeh

Pharmaceutical Sciences Research Center, Shiraz University Of Medical Sciences, Shiraz, Iran

Abdollah Arjmand

Department of Toxicology and Pharmacology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Narges Abdoli

Food and Drug Administration, Iran Ministry of Health and Medical Education, Tehran, Iran

Asma Najibi

Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Forouzan Khodaei

Pharmaceutical Sciences Research Center, Shiraz university of Medical Sciences, Shiraz, Iran

Sepideh Alidaee

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Negar Azarpira

Transplant Research Center, Shiraz University of Medical Sciences

Mohammad Mehdi Ommati

College of Life Sciences, Shanxi Agricultural University, Taigu, Shanxi ۰۳۰۸۰۱, Peoples’ Republic of China

Reza Heidari

Shiraz University of Medical Sciences, Pharmaceutical Sciences Research Center